28.04.2020 Shionogi receives European Commission Marketing Authorisation for Fetcroja® (cefiderocol) for the treatment of infections due to aerobic gram-negative bacteria In adults with limited treatment options
To improve your experience, this website uses cookies for analytics and functionality purposes. More information about how we use cookies and how you can control them is in our Cookie Policy. By continuing to use our website you agree to our use of these cookies.
